Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Veracyte (VCYT) Equity Average (2016 - 2026)

Veracyte's Equity Average history spans 13 years, with the latest figure at $1.3 billion for Q4 2025.

  • On a quarterly basis, Equity Average rose 9.15% to $1.3 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $1.3 billion, a 9.15% increase, with the full-year FY2025 number at $1.2 billion, up 11.96% from a year prior.
  • Equity Average hit $1.3 billion in Q4 2025 for Veracyte, up from $1.2 billion in the prior quarter.
  • Over the last five years, Equity Average for VCYT hit a ceiling of $1.3 billion in Q4 2025 and a floor of $697.7 million in Q1 2021.
  • Historically, Equity Average has averaged $1.1 billion across 5 years, with a median of $1.1 billion in 2023.
  • Biggest five-year swings in Equity Average: soared 326.09% in 2021 and later fell 3.64% in 2022.
  • Tracing VCYT's Equity Average over 5 years: stood at $1.1 billion in 2021, then decreased by 3.64% to $1.1 billion in 2022, then decreased by 1.19% to $1.0 billion in 2023, then grew by 12.1% to $1.2 billion in 2024, then grew by 9.15% to $1.3 billion in 2025.
  • Business Quant data shows Equity Average for VCYT at $1.3 billion in Q4 2025, $1.2 billion in Q3 2025, and $1.2 billion in Q2 2025.